Phase II Trial of Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Trastuzumab (Primary) ; Vinflunine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 May 2011 Actual end date (1 Nov 2010) added as reported by ClinicalTrials.gov.
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2007 Status changed from recruiting to suspended according to ClinicalTrials.gov.